Delivery Order SPE2DB22D1002-SPE2DB25FLDA0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,597.88 to AmerisourceBergen Drug Corp for 1,440 units/mL of Havrix vaccine in syringes. The contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, utilizes a firm fixed price structure with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $10,140.60 to AmerisourceBergen Drug Corp for 1,440 units/mL of Havrix vaccine in syringe form. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure, with an ultimate completion date of July 21, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,547.93 firm fixed price delivery order to AmerisourceBergen Drug Corp for 1,440 units/ml of Havrix vaccine in syringes. The award was made on September 8, 2025, with an ultimate completion date of September 9, 2025, and represents a non-competitive, non-set-aside delivery order. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for 1,440 units of Havrix 1-unit/mL vaccine syringes, valued at $6,200.90 under a firm fixed-price contract type. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 billion through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $9,508.18 to AmerisourceBergen Drug Corp for 1,440 units/mL of HAVRIX vaccine in syringe form. This competitively awarded, firm fixed-price delivery order was finalized on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a $11,463.02 delivery order to AmerisourceBergen Drug Corp for 1,440 units/mL of HAVRIX vaccine syringes on July 28, 2025, with completion targeted for July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be...
- The Defense Logistics Agency awarded a $5,016.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 1,440 units/mL of HAVRIX vaccine in syringe form. This competitively awarded contract, with no set-aside designation, was issued on May 19, 2025, with an ultimate completion date of May 20, 2025. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency has awarded a delivery order valued at $20,231.75 to AmerisourceBergen Drug Corp for the supply of 1,440 units/mL of HAVRIX vaccine in syringe form. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, awarded on August 4, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for 1,440 units of Havrix 1,440 Unit/ML syringes, with a ceiling value of $1,475.43. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025. The contract is not set-aside and was awarded competitively. AmerisourceBergen Drug Corp will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,048.80 delivery order to AmerisourceBergen Drug Corp for Havrix 720 Unit/0.5 ML syringes on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The vaccine product will be...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLDA0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,613.80 to AmerisourceBergen Drug Corp for 1,440 units/mL of Havrix vaccine in syringe form. This is a firm fixed price, non-set-aside contract with an ultimate completion date of June 4, 2025, and represents a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the location of performance for this delivery order, which falls under the company's broader relationship with the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued as a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Havrix vaccine procurement reflects the Defense Logistics Agency's ongoing need for critical immunization products to support military personnel and other federal healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 6/3/25 |